Eli Lilly and Company
LLY
#15
Rank
$1.061 T
Marketcap
United States
Country
$1,189.41
Share price
-2.11%
Change (1 day)
49.14%
Change (1 year)
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N,…
Key Metrics
Trailing P/E
38.17
Forward P/E
24.36
EPS (TTM)
$30.19
Forward EPS
$47.34
Price / Book
30.33
EV / EBITDA
25.7x
Beta
0.50
Dividend Yield
0.61%
Return on Equity
102.29%
Return on Assets
20.36%
Debt / Equity
162.07
Current Ratio
1.35
Gross Margin
83.40%
Operating Margin
54.22%
Net Profit Margin
33.53%
Free Cash Flow
$11.066B
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 19 – Sep 16
-11.13%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$65.179B
Latest Net Income$20.640B
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Eli Lilly and Company with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
LLY
No recent news available. Set FINNHUB_API_KEY to enable news.
